How MedTech Innovators Can Win Payer Coverage Outside Heart Failure, Cancer, and Diabetes
Published on: 16/11/2025
Think your device won’t get payer traction because it’s outside the “big three”? This article breaks down how MedTech companies targeting niche patient populations can still win with U.S. payers by aligning with quality metrics, cost savings, and equity priorities.
MedTech reimbursementpayer coverage strategyniche patient populationhealthcare innovationU.S. payersmedical device commercializationmarket accessquality metricscost of carerare diseases
The Myth of the Perfect Study for U.S. Market Access
Published on: 12/08/2025
One study rarely unlocks full payer coverage. Learn why U.S. market access requires a portfolio of evidence, strategic sequencing, and payer-specific insights.
evidencemarket access
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier
Published on: 06/02/2025
Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.
first-mover advantage in reimbursementreimbursement strategy for medical devicespayer evidence requirementsMedTech reimbursement challengescomparative coverage thresholdsclinical trial evidenceCMS policyhealthcare payerscoverage approvalmarket accesscoding and paymentreal-world evidencemedical device innovationwhy it’s harder for new MedTech companies to get coveragehow to compete with an already reimbursed medical device
